Maeshima Y - Search Results

1

An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.

Kobayashi R, Wakui H, Azushima K, Uneda K, Haku S, Ohki K, Haruhara K, Kinguchi S, Matsuda M, Ohsawa M, Toya Y, Nishiyama A, Yamashita A, Tanabe K, Maeshima Y, Umemura S, Tamura K. Kobayashi R, et al. Among authors: maeshima y. Kidney Int. 2017 May;91(5):1115-1125. doi: 10.1016/j.kint.2016.10.035. Epub 2017 Jan 10. Kidney Int. 2017. PMID: 28081856 Free article.

2

Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model.

Hashimoto N, Maeshima Y, Satoh M, Odawara M, Sugiyama H, Kashihara N, Matsubara H, Yamasaki Y, Makino H. Hashimoto N, et al. Among authors: maeshima y. Am J Physiol Renal Physiol. 2004 Mar;286(3):F516-25. doi: 10.1152/ajprenal.00294.2003. Epub 2003 Oct 28. Am J Physiol Renal Physiol. 2004. PMID: 14583437 Free article.

3

Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.

Takazawa Y, Maeshima Y, Kitayama H, Yamamoto Y, Kawachi H, Shimizu F, Matsui H, Sugiyama H, Yamasaki Y, Makino H. Takazawa Y, et al. Among authors: maeshima y. Kidney Int. 2005 Aug;68(2):704-22. doi: 10.1111/j.1523-1755.2005.00449.x. Kidney Int. 2005. PMID: 16014048 Free article.

4

Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice.

Kobayashi M, Sugiyama H, Wang DH, Toda N, Maeshima Y, Yamasaki Y, Masuoka N, Yamada M, Kira S, Makino H. Kobayashi M, et al. Among authors: maeshima y. Kidney Int. 2005 Sep;68(3):1018-31. doi: 10.1111/j.1523-1755.2005.00494.x. Kidney Int. 2005. PMID: 16105032 Free article.

5

Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model.

Tanabe K, Maeshima Y, Ichinose K, Kitayama H, Takazawa Y, Hirokoshi K, Kinomura M, Sugiyama H, Makino H. Tanabe K, et al. Among authors: maeshima y. Kidney Int. 2007 Feb;71(3):227-38. doi: 10.1038/sj.ki.5002040. Epub 2006 Dec 27. Kidney Int. 2007. PMID: 17191085 Free article.

6

Amelioration of cisplatin-induced acute renal injury by renal progenitor-like cells derived from the adult rat kidney.

Kinomura M, Kitamura S, Tanabe K, Ichinose K, Hirokoshi K, Takazawa Y, Kitayama H, Nasu T, Sugiyama H, Yamasaki Y, Sugaya T, Maeshima Y, Makino H. Kinomura M, et al. Among authors: maeshima y. Cell Transplant. 2008;17(1-2):143-58. doi: 10.3727/000000008783907008. Cell Transplant. 2008. PMID: 18468244 Free article.

7

Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.

Nasu T, Maeshima Y, Kinomura M, Hirokoshi-Kawahara K, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H. Nasu T, et al. Among authors: maeshima y. Diabetes. 2009 Oct;58(10):2365-75. doi: 10.2337/db08-1790. Epub 2009 Jul 8. Diabetes. 2009. PMID: 19587360 Free PMC article.

8

Inflammatory cytokine-induced expression of vasohibin-1 by rheumatoid synovial fibroblasts.

Miyake K, Nishida K, Kadota Y, Yamasaki H, Nasu T, Saitou D, Tanabe K, Sonoda H, Sato Y, Maeshima Y, Makino H. Miyake K, et al. Among authors: maeshima y. Acta Med Okayama. 2009 Dec;63(6):349-58. doi: 10.18926/AMO/31820. Acta Med Okayama. 2009. PMID: 20035291 Free article.

9

Intermittent administration of a sustained-release prostacyclin analog ONO-1301 ameliorates renal alterations in a rat type 1 diabetes model.

Yamasaki H, Maeshima Y, Nasu T, Saito D, Tanabe K, Hirokoshi-Kawahara K, Sugiyama H, Sakai Y, Makino H. Yamasaki H, et al. Among authors: maeshima y. Prostaglandins Leukot Essent Fatty Acids. 2011 Mar-Apr;84(3-4):99-107. doi: 10.1016/j.plefa.2010.11.005. Epub 2010 Dec 21. Prostaglandins Leukot Essent Fatty Acids. 2011. PMID: 21177088

10

Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis.

Saito D, Maeshima Y, Nasu T, Yamasaki H, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H. Saito D, et al. Among authors: maeshima y. Am J Physiol Renal Physiol. 2011 Apr;300(4):F873-86. doi: 10.1152/ajprenal.00503.2010. Epub 2011 Jan 12. Am J Physiol Renal Physiol. 2011. PMID: 21228103 Free article.

We recently reported the therapeutic effects of vasohibin-1 (VASH-1), an endogenous angiogenesis inhibitor, in a type 1 diabetic nephropathy model (Nasu T, Maeshima Y, Kinomura M, Hirokoshi-Kawahara K, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H. ...

We recently reported the therapeutic effects of vasohibin-1 (VASH-1), an endogenous angiogenesis inhibitor, in a type 1 diabetic nephropathy …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters